$LFCR
LIFECORE BIOMEDICAL, INC. \DE\ Stock $lfcr

$lfcr Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-Q Financial Statement

#000100528622000005 Filed on January 07, 2022

Income Statement

Concept	2021 Q4	2020 Q4
Revenue	$129.5M	$130.9M
YoY Change	-1.08%	-8.2%
Cost Of Revenue	$116.5M	$110.3M
YoY Change	5.65%	-13.23%
Gross Profit	$12.99M	$20.64M
YoY Change	-37.05%	33.02%
Gross Profit Margin	10.03%	15.76%
Selling, General & Admin	$13.84M	$16.11M
YoY Change	-14.1%	-14.0%
% of Gross Profit	106.49%	78.04%
Research & Development	$2.718M	$2.572M
YoY Change	5.68%	-8.86%
% of Gross Profit	20.92%	12.46%
Depreciation & Amortization	$5.905M	$4.730M
YoY Change	24.84%	4.42%
% of Gross Profit	45.45%	22.92%
Operating Expenses	$50.02M	$22.10M
YoY Change	126.31%	2.57%
Operating Profit	-$37.03M	-$1.466M
YoY Change	2425.92%	-75.71%
Interest Expense	$4.333M	$3.039M
YoY Change	42.58%	40.11%
% of Operating Profit
Other Income/Expense, Net	$79.00K	-$11.79M
YoY Change	-100.67%	196350.0%
Pretax Income	-$41.27M	-$16.00M
YoY Change	157.89%	102.42%
Income Tax	-$2.824M	-$2.700M
% Of Pretax Income
Net Earnings	-$38.44M	-$13.30M
YoY Change	189.01%	97.34%
Net Earnings / Revenue	-29.69%	-10.16%
Basic Earnings Per Share	-$1.30	-$0.45
Diluted Earnings Per Share	-$1.30	-$0.45
COMMON SHARES
Basic Shares Outstanding	29.47M shares	29.28M shares
Diluted Shares Outstanding	29.47M shares	29.28M shares

Balance Sheet

Concept	2021 Q4	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.091M	$2.500M
YoY Change	-56.36%	56.25%
Cash & Equivalents	$1.091M	$2.491M
Short-Term Investments
Other Short-Term Assets	$8.721M	$13.90M
YoY Change	-37.26%	37.62%
Inventory	$79.43M	$71.20M
Prepaid Expenses
Receivables	$65.28M	$66.55M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$154.5M	$154.2M
YoY Change	0.22%	9.99%
LONG-TERM ASSETS
Property, Plant & Equipment	$179.9M	$171.0M
YoY Change	5.24%	-16.47%
Goodwill	$37.33M	$69.39M
YoY Change	-46.2%	-10.18%
Intangibles	$25.33M	$4.200M
YoY Change	503.05%	-85.97%
Long-Term Investments	$0.00	$45.10M
YoY Change	-100.0%	-26.43%
Other Assets	$3.239M	$1.332M
YoY Change	143.17%	-48.43%
Total Long-Term Assets	$267.6M	$345.0M
YoY Change	-22.43%	-17.83%
TOTAL ASSETS
Total Short-Term Assets	$154.5M	$154.2M
Total Long-Term Assets	$267.6M	$345.0M
Total Assets	$422.1M	$499.2M
YoY Change	-15.43%	-10.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$59.10M	$60.89M
YoY Change	-2.95%	29.16%
Accrued Expenses	$20.01M	$24.20M
YoY Change	-17.33%	3.86%
Deferred Revenue	$1.160M	$644.0K
YoY Change	80.12%	5.4%
Short-Term Debt	$42.00M	$77.00M
YoY Change	-45.45%	25.2%
Long-Term Debt Due	$0.00	$11.19M
YoY Change	-100.0%	-4.56%
Total Short-Term Liabilities	$122.3M	$173.9M
YoY Change	-29.7%	20.47%
LONG-TERM LIABILITIES
Long-Term Debt	$124.2M	$82.00M
YoY Change	51.46%	-23.7%
Other Long-Term Liabilities	$3.894M	$5.357M
YoY Change	-27.31%	-81.2%
Total Long-Term Liabilities	$128.1M	$87.36M
YoY Change	46.63%	-18.71%
TOTAL LIABILITIES
Total Short-Term Liabilities	$122.3M	$173.9M
Total Long-Term Liabilities	$128.1M	$87.36M
Total Liabilities	$265.9M	$290.2M
YoY Change	-8.37%	-3.56%
SHAREHOLDERS EQUITY
Retained Earnings	-$9.338M	$46.94M
YoY Change	-119.89%	-52.05%
Common Stock	$29.00K	$29.00K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$156.2M	$208.9M
YoY Change
Total Liabilities & Shareholders Equity	$422.1M	$499.2M
YoY Change	-15.43%	-10.86%

Cashflow Statement

Concept	2021 Q4	2020 Q4
OPERATING ACTIVITIES
Net Income	-$38.44M	-$13.30M
YoY Change	189.01%	97.34%
Depreciation, Depletion And Amortization	$5.905M	$4.730M
YoY Change	24.84%	4.42%
Cash From Operating Activities	-$5.137M	$1.440M
YoY Change	-456.74%	-115.19%
INVESTING ACTIVITIES
Capital Expenditures	-$5.097M	-$2.790M
YoY Change	82.69%	-53.88%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$8.030M
YoY Change	-100.0%	11371.43%
Cash From Investing Activities	-$5.097M	$5.250M
YoY Change	-197.09%	-187.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	9.878M	-4.980M
YoY Change	-298.35%	-133.09%
NET CHANGE
Cash From Operating Activities	-5.137M	1.440M
Cash From Investing Activities	-5.097M	5.250M
Cash From Financing Activities	9.878M	-4.980M
Net Change In Cash	-356.0K	1.710M
YoY Change	-120.82%	-527.5%
FREE CASH FLOW
Cash From Operating Activities	-$5.137M	$1.440M
Capital Expenditures	-$5.097M	-$2.790M
Free Cash Flow	-$40.00K	$4.230M
YoY Change	-100.95%	-223.32%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001005286
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--05-29
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Amendment Flag AmendmentFlag	false
CY2020Q4	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
CY2021Q4	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
CY2020Q4	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
CY2021Q4	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
	dei	Document Type DocumentType	10-Q
	dei	Entity File Number EntityFileNumber	000-27446
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2021-11-28
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Registrant Name EntityRegistrantName	LANDEC CORPORATION
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	94-3025618
	dei	Entity Address Address Line1 EntityAddressAddressLine1	2811 Airpark Drive
	dei	Entity Address City Or Town EntityAddressCityOrTown	Santa Maria,
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	93455
	dei	City Area Code CityAreaCode	650
	dei	Local Phone Number LocalPhoneNumber	306-1650
	dei	Security12b Title Security12bTitle	Common stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	LNDC
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q4	lndc	Finite Lived Customer Lists Net FiniteLivedCustomerListsNet	9799000	USD
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3611000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	179929000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	179559000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	11979000	USD
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	20827000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	37329000	USD
CY2021Q2	us-gaap	Goodwill Goodwill	69386000	USD
CY2021Q4	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	25328000	USD
CY2021Q2	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	25328000	USD
CY2021Q2	lndc	Finite Lived Customer Lists Net FiniteLivedCustomerListsNet	10792000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3239000	USD
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	29481330	shares
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1091000	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1295000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	65276000	USD
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	70013000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	79433000	USD
CY2021Q2	us-gaap	Inventory Net InventoryNet	69663000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8721000	USD
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7350000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	154521000	USD
CY2021Q2	us-gaap	Assets Current AssetsCurrent	148321000	USD
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	0	USD
CY2021Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	45100000	USD
CY2021Q4	us-gaap	Assets Assets	422124000	USD
CY2021Q2	us-gaap	Assets Assets	502924000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	59098000	USD
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	47569000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7214000	USD
CY2021Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	12304000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	9804000	USD
CY2021Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	7996000	USD
CY2021Q4	lndc	Operating And Finance Lease Liability Current OperatingAndFinanceLeaseLiabilityCurrent	2988000	USD
CY2021Q2	lndc	Operating And Finance Lease Liability Current OperatingAndFinanceLeaseLiabilityCurrent	3889000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1160000	USD
CY2021Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1130000	USD
CY2021Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	42000000	USD
CY2021Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	29000000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	122264000	USD
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	101888000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	124194000	USD
CY2021Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	164902000	USD
CY2021Q4	lndc	Operating And Finance Lease Liability Noncurrent OperatingAndFinanceLeaseLiabilityNoncurrent	14203000	USD
CY2021Q2	lndc	Operating And Finance Lease Liability Noncurrent OperatingAndFinanceLeaseLiabilityNoncurrent	23611000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1367000	USD
CY2021Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	6140000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3894000	USD
CY2021Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3599000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	265922000	USD
CY2021Q2	us-gaap	Liabilities Liabilities	300140000	USD
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29481000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29481000	shares
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29333000	shares
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29333000	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	29000	USD
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	29000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	166327000	USD
CY2021Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	165533000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9338000	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	38580000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-816000	USD
CY2021Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1358000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	156202000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	202784000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	422124000	USD
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	502924000	USD
CY2021Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	129492000	USD
CY2020Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	130904000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	258280000	USD
CY2021Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	1400000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	266547000	USD
CY2021Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	116500000	USD
CY2020Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	110267000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	227769000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	229564000	USD
CY2021Q4	us-gaap	Gross Profit GrossProfit	12992000	USD
CY2020Q4	us-gaap	Gross Profit GrossProfit	20637000	USD
	us-gaap	Gross Profit GrossProfit	30511000	USD
	us-gaap	Gross Profit GrossProfit	36983000	USD
CY2021Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2718000	USD
CY2020Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2572000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5544000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5080000	USD
CY2021Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	13835000	USD
CY2020Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	16106000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	29774000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	34009000	USD
CY2021Q4	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	32057000	USD
CY2020Q4	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	32057000	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021Q4	us-gaap	Legal Fees LegalFees	0	USD
CY2020Q4	us-gaap	Legal Fees LegalFees	1763000	USD
	us-gaap	Legal Fees LegalFees	0	USD
	us-gaap	Legal Fees LegalFees	1763000	USD
CY2021Q4	us-gaap	Restructuring Charges RestructuringCharges	1412000	USD
CY2020Q4	us-gaap	Restructuring Charges RestructuringCharges	1662000	USD
	us-gaap	Restructuring Charges RestructuringCharges	3974000	USD
	us-gaap	Restructuring Charges RestructuringCharges	10066000	USD
CY2021Q4	us-gaap	Operating Expenses OperatingExpenses	50022000	USD
CY2020Q4	us-gaap	Operating Expenses OperatingExpenses	22103000	USD
	us-gaap	Operating Expenses OperatingExpenses	71349000	USD
	us-gaap	Operating Expenses OperatingExpenses	50918000	USD
CY2021Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-37030000	USD
CY2020Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-1466000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-40838000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13935000	USD
CY2021Q4	us-gaap	Investment Income Dividend InvestmentIncomeDividend	0	USD
CY2020Q4	us-gaap	Investment Income Dividend InvestmentIncomeDividend	281000	USD
	us-gaap	Investment Income Dividend InvestmentIncomeDividend	0	USD
	us-gaap	Investment Income Dividend InvestmentIncomeDividend	563000	USD
CY2021Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	19000	USD
CY2020Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	10000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	46000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	18000	USD
CY2021Q4	us-gaap	Interest Expense InterestExpense	4333000	USD
CY2020Q4	us-gaap	Interest Expense InterestExpense	3039000	USD
	us-gaap	Interest Expense InterestExpense	12250000	USD
	us-gaap	Interest Expense InterestExpense	6148000	USD
CY2021Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	79000	USD
CY2020Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-11787000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	188000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-11808000	USD
CY2021Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-41265000	USD
CY2020Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16001000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-52854000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-31310000	USD
CY2021Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2824000	USD
CY2020Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2700000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4936000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7009000	USD
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-38441000	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-13301000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-47918000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-24301000	USD
CY2021Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.30
CY2020Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.63
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.83
CY2021Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.30
CY2021Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29471000	shares
CY2020Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.63
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.83
CY2020Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29280000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29448000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29261000	shares
CY2021Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29471000	shares
CY2020Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29280000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29448000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29261000	shares
CY2021Q4	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	-100000	USD
CY2020Q4	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	-121000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	-190000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	-228000	USD
CY2021Q4	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	176000	USD
CY2020Q4	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	401000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	542000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	705000	USD
CY2021Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	176000	USD
CY2020Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	401000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	542000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	705000	USD
CY2021Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-38265000	USD
CY2020Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12900000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-47376000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-23596000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	202784000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	USD
CY2021Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	428000	USD
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	620000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-9477000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	366000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	193865000	USD
CY2021Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	USD
CY2021Q4	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	84000	USD
CY2021Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	686000	USD
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-38441000	USD
CY2021Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	176000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	156202000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	231044000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	USD
CY2020Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	82000	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	892000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-11000000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	304000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	221158000	USD
CY2020Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	USD
CY2020Q4	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	215000	USD
CY2020Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	895000	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-13301000	USD
CY2020Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	401000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	208938000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-47918000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-24301000	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	32057000	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10959000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9826000	USD
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-4963000	USD
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-7070000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1306000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1787000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	196000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	102000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-22000	USD
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	1163000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	34000	USD
	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	-92000	USD
	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	6005000	USD
	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	0	USD
	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-11800000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	111000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-21000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-4541000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-9559000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	9770000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4891000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1784000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1539000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	15148000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	10539000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-5090000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-1345000	USD
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	4627000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	30000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	292000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4306000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	18456000	USD
	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	45100000	USD
	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13010000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7407000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1082000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	12885000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	33172000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	5478000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	41426000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	20062000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	26000000	USD
CY2021Q4	lndc	Number Of Product Category NumberOfProductCategory	2	product
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	24000000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	13000000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	24400000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	132000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1237000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	512000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	297000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-29070000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-21996000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-204000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1938000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1295000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	553000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1091000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2491000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1105000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1526000	USD
CY2021Q4	lndc	Number Of Revenue Category NumberOfRevenueCategory	3	revenue
	us-gaap	Fiscal Period FiscalPeriod	<div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s fiscal year is the 52- or 53-week period that ends on the last Sunday of May with quarters within each year ending on the last Sunday of August, November, and February; however, in instances where the last Sunday would result in a quarter being 12-weeks in length, the Company’s policy is to extend that quarter to the following Sunday. A 14th week is included in the fiscal year every five or six years to realign the Company’s fiscal quarters with calendar quarters.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for the six months ended November 28, 2021 are not necessarily indicative of the results that may be expected for an entire fiscal year because there is some seasonality in Curation Foods’ business and the order patterns of Lifecore’s customers which may lead to significant fluctuations in Landec’s quarterly results of operations.</span></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make certain estimates and judgments that affect the amounts reported in the financial statements and accompanying notes. The accounting estimates that require management’s most significant and subjective judgments include revenue recognition; loss contingencies; sales returns and credit losses; recognition and measurement of current and deferred income tax assets and liabilities; the assessment of recoverability of long-lived and indefinite lived assets (including intangible assets), and inventory; and the valuation and recognition of stock-based compensation.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These estimates involve the consideration of complex factors and require management to make judgments. The analysis of historical and future trends can require extended periods of time to resolve and are subject to change from period to period. The actual results may differ from management’s estimates.</span></div>
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1091000	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1295000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2491000	USD
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	360000	USD
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	0	USD
CY2021Q2	us-gaap	Restricted Cash RestrictedCash	0	USD
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	0	USD
CY2020Q2	us-gaap	Restricted Cash RestrictedCash	193000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1091000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1295000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2491000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	553000	USD
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	42967000	USD
CY2021Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	39493000	USD
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	31924000	USD
CY2021Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	23942000	USD
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	4542000	USD
CY2021Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	6228000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	79433000	USD
CY2021Q2	us-gaap	Inventory Net InventoryNet	69663000	USD
CY2020Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	438000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	102000	USD
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	263000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	277000	USD
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	279000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	196000	USD
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	148000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	327000	USD
CY2021Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	4500000	USD
CY2021Q2	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	1400000	USD
CY2021Q2	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	5100000	USD
	us-gaap	Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths	-500000	USD
CY2021Q1	us-gaap	Insurance Recoveries InsuranceRecoveries	1600000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	200000	USD
CY2020Q3	lndc	Loss Contingency Number Of Former Owner Plaintiff LossContingencyNumberOfFormerOwnerPlaintiff	1	plaintiff
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	703000	shares
CY2021Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	3800000	shares
CY2021Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	686000	USD
CY2020Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	892000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1306000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1787000	USD
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	3900000	USD
CY2010Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	10000000	USD
CY2021Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	3800000	USD
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-38441000	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-13301000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-47918000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-24301000	USD
CY2021Q4	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	29471000	shares
CY2020Q4	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	29280000	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	29448000	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	29261000	shares
CY2021Q4	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2020Q4	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29448000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2021Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29471000	shares
CY2020Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29280000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29261000	shares
CY2021Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.30
CY2020Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.63
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.83
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4900000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7000000	USD
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.09
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.22
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1100000	USD
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	900000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	1000000	USD
CY2021Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	800000	USD
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	128647000	USD
CY2021Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	170000000	USD
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	4453000	USD
CY2021Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5098000	USD
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	124194000	USD
CY2021Q2	us-gaap	Long Term Debt LongTermDebt	164902000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2021Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	124194000	USD
CY2021Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	164902000	USD
	us-gaap	Gross Profit GrossProfit	30511000	USD
CY2020Q4	lndc	Number Of Credit Agreements NumberOfCreditAgreements	2	creditAgreement
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2021Q4	lndc	Number Of Natural Food Brands NumberOfNaturalFoodBrands	4	brand
CY2021Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	129492000	USD
CY2021Q4	us-gaap	Gross Profit GrossProfit	12992000	USD
CY2021Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-38441000	USD
CY2021Q4	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	5232000	USD
CY2021Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	19000	USD
CY2021Q4	us-gaap	Interest Expense InterestExpense	4333000	USD
CY2021Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2824000	USD
CY2021Q4	lndc	Corporate Overhead Expense Benefit CorporateOverheadExpenseBenefit	0	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	258280000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	46000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-47918000	USD
	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	9996000	USD
	us-gaap	Interest Expense InterestExpense	12250000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4936000	USD
	lndc	Corporate Overhead Expense Benefit CorporateOverheadExpenseBenefit	0	USD
CY2020Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	130904000	USD
CY2020Q4	us-gaap	Gross Profit GrossProfit	20637000	USD
CY2020Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-13301000	USD
CY2020Q4	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	4292000	USD
CY2020Q4	us-gaap	Investment Income Dividend InvestmentIncomeDividend	281000	USD
CY2020Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	10000	USD
CY2020Q4	us-gaap	Interest Expense InterestExpense	3039000	USD
CY2020Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2700000	USD
CY2020Q4	lndc	Corporate Overhead Expense Benefit CorporateOverheadExpenseBenefit	0	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	266547000	USD
CY2021Q4	us-gaap	Restructuring And Related Cost Expected Cost1 RestructuringAndRelatedCostExpectedCost1	45000000	USD
	us-gaap	Gross Profit GrossProfit	36983000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-24301000	USD
	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	9039000	USD
	us-gaap	Investment Income Dividend InvestmentIncomeDividend	563000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	18000	USD
	us-gaap	Interest Expense InterestExpense	6148000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7009000	USD
	lndc	Corporate Overhead Expense Benefit CorporateOverheadExpenseBenefit	0	USD
CY2021Q4	us-gaap	Restructuring Costs RestructuringCosts	1412000	USD
	us-gaap	Restructuring Costs RestructuringCosts	3974000	USD
	us-gaap	Restructuring Costs RestructuringCosts	41442000	USD

Files In Submission

Name	View Source	Status
0001005286-22-000005-index-headers.html	Edgar Link	pending
0001005286-22-000005-index.html	Edgar Link	pending
0001005286-22-000005.txt	Edgar Link	pending
0001005286-22-000005-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
lndc-20211128.htm	Edgar Link	pending
lndc-20211128.xsd	Edgar Link	pending
lndc-20211128xexx311.htm	Edgar Link	pending
lndc-20211128xexx312.htm	Edgar Link	pending
lndc-20211128xexx321.htm	Edgar Link	pending
lndc-20211128xexx322.htm	Edgar Link	pending
lndc-20211128_cal.xml	Edgar Link	unprocessable
lndc-20211128_def.xml	Edgar Link	unprocessable
lndc-20211128_htm.xml	Edgar Link	completed
lndc-20211128_lab.xml	Edgar Link	unprocessable
lndc-20211128_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LFCR
LIFECORE BIOMEDICAL, INC. \DE\ Stock $lfcr

2021 Q4 Form 10-Q Financial Statement

#000100528622000005 Filed on January 07, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFCR LIFECORE BIOMEDICAL, INC. \DE\ Stock $lfcr

2021 Q4 Form 10-Q Financial Statement

#000100528622000005 Filed on January 07, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFCR
LIFECORE BIOMEDICAL, INC. \DE\ Stock $lfcr